Doximity, Inc. Class A
As of Oct 22, 2026, Doximity is in Stage 2, the uptrend phase, now in week 2 (since Oct 14, 2026). It closed at $33.68, 50.8% below its 52-week high and above its 200-day average, which is falling.
Doximity, Inc. operates a digital platform for medical professionals in the United States. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 16 in Health Information Services · #1 of 272 in Health Care
Is DOCS early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
DOCS among Health Information Services27th of 41 by relative strength
All 41 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | AMWL | Stage 2 · wk 25 | 97 | +7.4% |
| 2 | HNGE | Stage 2 · wk 20 | 96 | +19.1% |
| 3 | BTSG | Stage 3 · wk 8 | 94 | +9.1% |
| 4 | NRC | Stage 3 · wk 4 | 93 | −0.1% |
| 5 | SOPH | Stage 2 · wk 24 | 91 | −12.7% |
| 6 | HTFL | Stage 2 · wk 10 | 87 | +17.0% |
| 7 | HSTM | Stage 2 · wk 17 | 77 | +20.3% |
| 8 | OMCL | Stage 4 · wk 10 | 70 | +12.5% |
| …27 | DOCS | Stage 2 · wk 2 | 23 | +26.8% |
Doximity: quick answers
What stage is Doximity in?
As of Oct 22, 2026, Doximity (DOCS) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 14, 2026 and is in week 2. What the four stages mean
Is Doximity in an uptrend?
Yes. Doximity is in a Stage 2 uptrend. It trades 30.3% above its 200-day average, which is falling.
How far is Doximity from its 52-week high?
Doximity closed at $33.68 on Oct 22, 2026, 50.8% below its 52-week high of $68.50. Its 52-week low is $18.01.
How has Doximity performed over the past year?
As of Oct 22, 2026, Doximity is down 50.4% over the past year and down 22.2% so far in 2026.
Which sector and industry is Doximity in?
Doximity is in the Health Information Services industry, part of the Health Care sector.
About this companyHealth Care· Health Information Services
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.